baber/WOPTO huggingface dataset:
Patent PT-1933869-E (PT)
Title: Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease
Inventor: TSAI VAN
IPC: A61P27/00
Filed: 2006-08-30
Abstract: Novel methods and drug products for treating autoimmune ocular inflammatory disease are disclosed, which involve administration of agents that antagonize one or both of IL-17 and IL-23 activity.
Patent PT-2147950-E (PT)
Title: Fiber reinforced plastic molding material and fiber reinforced plastic molded article
Inventor: KUROKI KUNIHIRO
IPC: C08J5/04
Filed: 2007-05-14
Abstract: Provided is a fiber reinforced plastic molding material which provides a cured product with excellent impact resistance, corrosion resistance and transparency. The fiber reinforced plastic molding material includes: a radical polymerizable resin composition containing: a vinyl ester resin (A) having a weight average molecular weight of 500 to 6,000; a urethane (meth)acrylate resin (B) obtained by reacting an isocyanate compound having two or more isocyanate groups in one molecule, a (meth)acrylic compound having one or more hydroxyl groups in one molecule and polyethylene glycol; an aliphatic amine (C) represented by the following general formula:   
where R1 represents a hydroxyalkyl group, R2 represents an alkyl group or a hydroxyalkyl group, and R3 represents H or CH 3 ; a metal soap of cobalt (D); and an organic peroxide (E); and a glass fiber reinforcing material (F).
Patent PT-2176229-E (PT)
Title: Novel crystalline form of 3-(difluormethyl)-1-methyl-n -(3',4',5'-trifluor[1,1'-biphenyl]-2-yl)-1h-pyrazol-4-carboxamide
Inventor: SAXELL HEIDI EMILIA
IPC: A01N43/56
Filed: 2008-07-07
Abstract: The present invention relates to a new crystalline form of 3-(Difluormethyl)-1-methyl-N-(3′,4′,5′-trifluor[1,1′-biphenyl]-2-yl)-1H-pyrazol-4-carboxamide. The invention also relates to processes for the production of this crystalline form and formulations for plant protection which contain the crystalline form of 3-(Difluormethyl)-1-methyl-N-(3′,4′,5′-trifluor[1,1′-biphenyl]-2-yl)-1H-pyrazol-4-carboxamide.
Patent PT-2249869-E (PT)
Title: Liquid formulation of fsh
Inventor: STOLZENBERGER SASCHA
IPC: A61K9/00
Filed: 2009-02-09
Abstract: The present invention relates to a liquid pharmaceutical composition comprising a follicle stimulating hormone polypeptide and benzalkonium chloride and benzyl alcohol as preservatives. The composition further comprises optionally one or more other pharmaceutically acceptable excipients. In one embodiment, the composition contains methionine as an antioxidant. The composition shows a good storage stability and is especially useful for the prophylaxis and treatment of disorders and medical indications where follicle stimulating hormone preparations are considered as useful remedies.
Patent PT-2305894-E (PT)
Title: A method for consolidating soils by injection
Inventor: KAUBER RODOLFO
IPC: C09K17/00
Filed: 2010-01-28
Abstract: A method for consolidating soils by injecting into the soil a bicomponent resin, derived from a reaction between polyols and isocynate, includes continuous alternating injection of at least two resins A and B which exhibit different nominal densities, alternation between the injected resins being a function of a variation of injection pressure, and/or of a flow rate of the injected resin through a nozzle.
Patent PT-2241295-E (PT)
Title: Devices for selective disruption of fatty tissue by controlled cooling
Inventor: ANDERSON RICHARD ROX
IPC: C12N5/077
Filed: 2003-03-17
Abstract: The present invention relates to methods for use in the selective disruption of lipid-rich cells by controlled cooling. The present invention further relates to a device for use in carrying out the methods for selective disruption of lipid-rich cells by controlled cooling.
Patent PT-690863-E (PT)
Inventor: MICHAELIDES MICHAEL R
IPC: A61K31/435
Filed: 1994-03-18
Abstract: A tetracyclic compound of the formula:   <IMAGE>   wherein A and the atoms to which it is attached and the optional double bond represent a mono- or di-heterocyclic ring selected from:   <IMAGE>    <IMAGE>   wherein R1, R2, R3, R4 and X are specifically defined, which compounds are useful in the treatment of dopamine-related neurological, psychological and cardiovascular disorders as well as in the treatment of substance abuse and other addictive behavior disorders, cognitive impairment and attention deficit disorder.
Patent PT-782862-E (PT)
Inventor: MAKOTO TSUKAMOTO
IPC: A01K67/027
Filed: 1995-08-31
Abstract: A genetic material containing composition comprising genes and a transporter that can transfer the same from the maternal body to the fetal cells. The composition, when administered to the maternal body, serves to prevent the birth of children suffering from gene deletion and to cure gene deletion during gestation. It is also possible by conducting an animal experiment for introducing unknown genes in an embryonal stage to clarify the function to be performed by the same in development. The composition c <IMAGE>
Patent PT-885220-E (PT)
Inventor: WATJEN FRANK
IPC: A61P25/28
Filed: 1997-02-21
Abstract: The present invention relates to novel tropane-derivatives which are valuable monoamine neurotransmitter, i.e dopamine, serotonin and noradrenaline, re-uptake inhibitors and the use of the novel tropane derivatives for the treatment of disorders or diseases responsive to the inhibition of monoamine neurotransmitter re-uptake, such as Parkinson's disease, depression, obsessive compulsive disorders, panic disorders, dementia, memory deficits, attention deficit hyperactivity disorder, obesity, anxiety, eating disorders and drug addiction or misuse, including cocaine abuse.
Patent PT-900633-E (PT)
Inventor: AUBRY CLAUDE
IPC: B25B27/10
Filed: 1998-06-26
Abstract: The clamp consists of a body (1) with a movable slider (2) which has a surface rack (24) to engage with the tip (50) of an articulated sleeve (5). The top of the body and slider have grooves (13,21) to receive jaws (3,4) which slide into position and are shaped to fit the fixing rings. The jaws have grooves (32,42) which match hose of the body and slider so that they form T-section couplings for sideways engagement and are equipped with sprung ball locks (14,22). A pivoted lock (6) controls the position of the sleeve (5) and the degree to which the jaws can be closed.
Patent PT-1100720-E (PT)
Inventor: TARDY JEAN-FRANCOIS
IPC: A62B99/00
Filed: 1999-08-03
Abstract: The present invention relates to a device suspended from a carrier craft for the recovery of persons or items of equipment, of the type comprising a connection (21) joining the craft to a foldable and deployable pod (20) formed by a framework associated with a flexible support (23).The framework includes, fixed to the connection (21), a central mast (2, 3) connected to mobile means (4, 6) bearing the flexible support (23), to ensure the folding and deployment of the mobile means and of the flexible support around the central mast.Application to the rescue of persons in danger from a helicopter.
Patent SG-52293-G (SG)
Title: Disposable diaper featuring crotch tensioning means for improved leakage resistance and fit
IPC: A61F13/15
Filed: 1993-04-22
Abstract: A disposable diaper (10) having front and rear waist portions and comprising a liquid permeable topsheet (50); a liquid impermeable backsheet (30) affixed to the topsheet; an absorbent core (40) interposed between the topsheet (50) and the backsheet (30); a crotch portion located intermediate the front and rear waist portions; a pair of side flaps; and crotch tensioning means (60) associated with each of the side flaps. The absorbent core (40) has oppositely disposed end portions and a pair of longitudinally disposed side edges therebetween. The crotch tensioning means (60) further comprises one or more elasticized members extending from an attachment area in the crotch portion of the diaper, across the respective side flap, to a location longitudinally outside of the crotch portion. The crotch tensioning means (60) thereby tend to impose outward lateral tension on the crotch portion of the diaper (10) when in use. The attachment areas for such crotch tensioning means (60) are preferably oppositely disposed within the crotch portion of the diaper (10) and are laterally spaced from one another at a width of less than approximately 153 mm. The resulting disposable diaper (10) provides improved aesthetic fit on the wearer and improved containment of voided materials.
Patent IE-38785-L (IE)
Title: 2, 2- ANHYDRO - 1ß -D -ARABINOFURANOSYL - 5 - FLUOROCYTOSINE
IPC: C07H19/06
Filed: 1974-01-07
Abstract: 2,2'-Anhydro-1 beta -D-arabinofuranosyl-5-fluorocytosine (hereafter AAFC) and its acid addition salts are known compounds. AAFC may now be conveniently prepared in extremely high yield by selective acid catalyzed hydrolysis of the corresponding 3'-O-acyl analogs of AAFC which unexpectedly hydrolyzes at the acyl group while the 2,2'-anhydro linkage remains intact.
[US4124757A]
Patent IE-830178-L (IE)
Title: Release tag compounds for use in chemical analysis
IPC: G01N33/532
Filed: 1983-01-31
Abstract: A new class of chemical reagents called release tags which comprise signal, release and reactivity groups is disclosed and a release tag involving a pentafluorobenzoyl signal group, a methionylamide release group, and an active ester reactivity group is used to analyze the hormone, thyroxine, in serum, involving quantitation of the released signal group by gas chromatography with electron capture detection.
[US4709016A]
Patent IE-820288-L (IE)
Title: FURO (3,4-c) PYRIDINE DERIVATIVES
IPC: A61P9/12
Filed: 1982-02-09
Abstract: This invention relates to new 1,3-dihydro-6-methyl-7-hydroxy-furo-(3,4-c)-pyridine derivatives of the general formula <IMAGE> wherein A< represents a group of the formula -(CH2)n-, n being an integer of from 1 to 5, or a homocyclic or heterocyclic group, and R represents a hydrogen, chlorine or fluorine atom, a trifluoromethyl group, an alkyl group having from 1 to 5 carbon atoms, an alkoxy group having from 1 to 5 carbon atoms, a alkylthio group having from 1 to 5 carbon atoms, a dialkylaminoalkoxy group in which the alkyl groups each have from 1 to 5 carbon atoms and the alkoxy group has from 1 to 5 carbon atoms or a N-pyrolidinyl-alkoxy group in which the alkoxy group has from 1 to 5 carbon atoms to a process for the preparation of the same by refluxing alpha 4, 3-o-isopropylidene-pyridoxal with a compound of the general formula X-A-R, wherein X represents a bromine or iodine atom, in the presence of magnesium in diethyl ether, and acidifying the resultant corresponding secondary alcohol alpha 4, 3-o-isopropylidene- alpha -hydroxy-5-substituted-pyridoxine to break the isopropylidene ring and promote a 3,4 cyclization; and to therapeutical compositions of matter comprising as an essential ingredient therein an effective amount of one of these compounds.
[US4383998A]
Patent IE-41351-L (IE)
Title: Electric cell
IPC: C25B13/04
Filed: 1975-02-28
Abstract: A diaphragm cell for the electrolytic production of chlorine and alkali metal hydroxide, in other respects conventional, is improved by the provision of a dimensionally stable, polymer-modified diaphragm together with a dimensionally adjustable anode capable of movement toward said diaphragm on cell assembly.
[US3928166A]
Patent IE-43133-L (IE)
Title: Halomethyl n-acyl heterocyclic compounds
IPC: C07D263/56
Filed: 1976-05-07
Abstract: Heterocyclic compounds of the general formula: <IMAGE> wherein: R1 represents alkyl, haloalkyl, alkenyl, haloalkenyl, arylalkyl, arylhaloalkyl, cycloalkyl, halocycloalkyl, aryl, haloaryl, alkoxyalkyl or haloalkoxyalkyl; X1 is chlorine, bromine, or fluorine; X2 and X3 are hydrogen, chlorine, bromine or fluorine; A represents oxygen or sulphur, S-O <IMAGE> or N-R8; R8 is hydrogen, alkyl, haloalkyl, hydroxyalkyl, alkoxyalkyl, arylalkyl, aryl or <IMAGE> B represents <IMAGE> m is 0, 1 or 2; n and p are 0 or 1; R2, R3, R4, R5, R6, R7, R'2, R'3, R'4, R'5 are the same or different and are hydrogen, alkyl, alkoxyalkyl, haloalkyl, or hydroxyalkyl; and Y and Z are the same or different and are hydrogen, halogen, alkyl or alkoxy. These compounds are used as antidotes against herbicides.
[US4197110A]
Patent FI-852322-L (FI)
Inventor: MAEDA SUSUMU
IPC: C12P21/02
Filed: 1985-06-11
Abstract: A method of producing useful substances which comprising propagating in cultured cells or in a host a recombinant Bombyx mori nuclear polyhedrosis virus (BmNPV) DNA is disclosed. The BmNPV DNA is produced by recombination with a double-stranded DNA containing (i) a 5'- upstream BmNPV DNA fragment originally occurring upstream from the structural gene coding for the production of polyhedral protein and also including the promotor region for the structural gene, (ii) a translational start codon and (iii) a gene coding for the production of a useful substance exogenous to the virus, with or without (iv) a 3'-downstream BmNPV DNA fragment originally occurring downstream from the structural gene coding for the production of polyhedral protein.
Patent FI-852785-L (FI)
Inventor: HUHTIKANGAS AARRE
IPC: G01N33/53
Filed: 1985-07-16
Abstract: The invention relates to a protein conjugate of bis- indole alkaloids, said conjugate having the structural formula I Ar-N=N-bis-indole alkaloid I wherein Ar is a bensoe or arylalkyl carboxylic acid group having a protein group. The invention further relates to a process for the preparation of protein conjugates of bis-indole alkaloids having the structural formula I. Bis- indole is reacted with a diazonium acid derivative of the formula <IMAGE> wherein Ar is as defined above with the proviso that Ar may be without a protein group, when the protein group is bound with the aromatic acid group. Conjugations having the structural formula I are useful in the preparation of antibodies which are used in immunometric assays of bis- indole alkaloids.
Patent IE-781029-L (IE)
Title: Cyclopropanecarboxylic acids
IPC: A01N53/12
Filed: 1978-05-24
Abstract: Cyclopropanecarboxanilides have the following formula <IMAGE> in which R1 is hydrogen or C1-C4-alkyl, R2 denotes an aromatic hydrocarbon radical or an aromatic hydrocarbon radical which is substituted one or more times by identical or different substituents comprising C1-C4-alkyl, C1-C4-alkoxy, C1-C4-alkylthio, halogen, trifluoromethyl, nitro, C1-C4-alkoxycarbonyl, C1-C4-alkylcarbonyl and/or cyano, and n denotes the number 1 or 2. The compounds of the formula I are prepared by reacting a cyclopropanecarbonyl chloride with an appropriate 3-anilino-2-perhydrofuran. Fungicides contain, as the active component, at least one new compound of the formula I.
[GB1603730A]
Patent IE-33299-L (IE)
Title: Treating animal waste
IPC: C05F3/00
Filed: 1969-08-20
Abstract: 1282772 Treating animal waste E ROHRER 19 Aug 1969 [22 Aug 1968] 41218/69 Heading C1C Waste arising from excreta in animal stalls, stables, sties &c. are quickly treated with a precipitant and/or a flocculant and the solids are separated by conventional means.
[GB1282772A]
Patent IE-32601-L (IE)
Title: Extruded sheet materials
IPC: B29C48/22
Filed: 1968-12-30
Abstract: 1,258,393. Extruding polymeric sheet material. O-B RASMUSSEN. 30 Dec., 1968 [29 Dec., 1967], No. 59141/67. Heading B5A. An extruded sheet material comprises lamellµ of a polymeric material which are bonded together to provide a continuous core, but are disconnected or only partially connected in the surface layers of the sheet. Preferably, the sheet material comprises lamellµ 2 of a second material which may also be polymeric and which are present in the surface layers only and either provide the partial connections or are disrupted to provide partial connections. Such disruption of the second material may be effected by reducing the material to a fibrous form, e.g. by the addition of a slipping agent which bleeds out on solidification of the material. Other disruptive methods or ways of separating the lamellµ include drawing, rolling, impacting, expanding, brushing, bending and acoustic or chemical action. Alternatively, the second material may be brushed or dissolved out. Preferably, the first material is crystalline and orientated and a further polymeric material may be interposed therewith to effect the bonding in the core of the sheet. An apparatus for producing such sheet material comprises an annular die 3 having slots 8 through which the first material is extruded and pairs of slots 9 in line or offset with respect to one another, for the second material. A converging collecting chamber 7 and extrusion slot 6 are defined by die parts 4, 5. During extrusion relative rotational movement occurs between die 3 and parts 4, 5 to impart a smearing action to the lamellµ. The form shown in Fig. 2 is produced by movement of die 3 and/or both parts 4, 5 in unison. The lamellµ are first folded to lie parallel to the extrusion face of die 3, continued extrusion forcing the lamellµ through slot 6 with smearing thereof to a generally U-shape. The form shown in Fig. 1 is produced by relative movement of parts 4, 5, the lamellµ being stretched to give a flattened S form when the sheet is viewed in cross-section. In a modification, two collecting chambers in series may be used in which the upstream chamber is partitioned to divide the flow such that rows of U- or S-shaped lamellµ are produced. Only the upstream chamber is moved. Die 3 and parts 4, 5 may be linear and relatively reciprocated.
[GB1258393A]
Patent IE-831602-L (IE)
Title: Magnetic apparatus
IPC: C23C16/54
Filed: 1983-07-08
Abstract: An apparatus for producing improved large area photovoltaic devices by substantially reducing the warpage of relatively large area, relatively thin webs of magnetic substrate material which travel through a plurality of high temperature, low pressure glow discharge deposition chambers. As the web of the substrate material moves through the deposition chambers, it assumes a normal, elongated path of travel. Due to the elevated deposition temperature, the elongated path of travel, the force of gravity, etc., the web has a tendency to warp. Warpage of the web is undesirable as it promotes the deposition of non-uniform semiconductor alloy layers. The improvement of the present invention contemplates the establishment of at least one magnetic field within each deposition chamber which is adapted to urge the web of substrate material out of its normal path of travel into a flat, substantially planar path of travel. The new flat path of travel serves to substantially reduce warpage of the web which permits uniform amorphous semiconductor alloy layers to be deposited. In alternate embodiments, the web of substrate material may be urged into sliding contact with a plurality of stationary ceramic magnets or the web may be urged into rolling contact with a plurality of rotatable magnetic elements which may either be hollow, ceramic magnets or electromagnets.
Patent IE-45178-L (IE)
Title: Phenothiazine derivatives
IPC: C07D279/28
Filed: 1977-08-02
Abstract: The present invention relates to novel behenic acid esters of the following general formula: <IMAGE> I wherein X is "N" or "CH," the non-toxic acid addition salts thereof, a method for the preparation of said esters and therapeutic compositions thereof having prolonged effect.
[US4153694A]
Patent IE-38332-L (IE)
Title: Surface coating compositions
IPC: C09C1/36
Filed: 1973-09-21
Abstract: The conjoint use of (a) a pigment treated with a hydrophilic agent and (b) a binder composition based on a component having a relatively high hydroxyl value in an organic solvent based coating composition. (From US3979343 A) [GB1393425A]
Patent IE-841917-L (IE)
Title: Control of parasites
IPC: A61K47/00
Filed: 1984-07-24
Abstract: The invention concerns a pour-on composition for topical application to animals to control endoparasites. The composition comprises an endoparasiticide and a carrier comprising at least one saturated aliphatic carboxylate ester of a mono-alkyl ether of a mono- or poly- alkylene glycol. The compositions show surprisingly improved efficacy and freedom from unacceptable skin reaction even when applied to sensitive breeds of animals. In further embodiments the invention provides a process for the treatment of animals to control or eradicate endoparasites and a process for preparing endoparasiticidal compositions.
Patent IE-891957-L (IE)
Title: Benzazepine and benzothiazepine derivatives
IPC: C07D405/14
Filed: 1989-06-16
Abstract: Vasodilating activity is exhibited by compounds having formula (I), wherein X can be -S- or -CH2?-; and R2? is (a), (b), (c), (d), (e), (f), (g), (h), (i) or (j), depending upon the definition of X.
[WO8912633A1]
Patent IE-40529-L (IE)
Title: Recovering sulphur dioxide
IPC: C01B17/60
Filed: 1974-10-08
Abstract: The method of recovering liquid sulphur dioxide from gases containing sulphur dioxide by washing with water in an absorption plant and then stripping off absorbed sulphur dioxide at subatmospheric pressure. Water is removed from the stripped gasesby cooling and drying and sulphur dioxide is removed by condensation. The whole system is kept at a subatmospheric pressure by pumping off residual gases after the sulphur dioxide condensation.
[SE7313965L]
Patent IE-892409-L (IE)
Title: 1,5-benzothiazepine derivatives, their preparation and their¹use in the treatment of cardiovascular disorders
IPC: C07D417/06
Filed: 1989-07-25
Abstract: Compounds of formula (I): <CHEM> [in which: R<1> is aryl or aromatic heterocyclic; R<2> and R<3> are hydrogen, alkyl, alkoxy, halogen, phenyl, phenoxy, C1 - C6 alkylthio, phenylthio, C1 - C6 haloalkyl, cyano or nitro, or together are alkylene optionally containing oxygen; R<4> is hydrogen, aliphatic acyl, cycloalkylcarbonyl, cycloalkoxycarbonyl, aromatic acyl, alkoxycarbonyl or benzyloxycarbonyl; R<5> and R<6> are alkyl; and X is oxygen, sulphur or methylene] have calcium channel blocking activity and can serve for the treatment or prophylaxis of cardiovascular diseases and disorders. They may be prepared by reacting a corresponding compound where R<4> is hydrogen and the aminoethyl group is replaced by hydrogen with a compound providing the aminoethyl group and then, if required, acylating the product.
[EP0353032A1]
Patent IE-842871-L (IE)
Title: Medium for storing blood platelets
IPC: A61K35/14
Filed: 1984-11-08
Abstract: A novel method of processing and storing human blood platelets is disclosed which comprises the replacement of about 35-45 mls of plasma per unit of blood platelets with a synthetic storage medium. This synthetic storage medium comprises a buffered Ringers-citrate solution which preferably contains a platelet permeable substrate for oxidative phosporylation. In the resultant platelet suspension, the amount of glucose available for glycolysis is preferably limited to less than about 10 mM, preferably less than about 5.0 mM. This platelet suspension is stored in an oxygen permeable container at about 20 DEG -24 DEG C. until needed for use. Using this method and medium platelets will maintain their viability for up to as long as about 7 days.
[EP0142339A1]
Patent IE-883130-L (IE)
Title: Vaccine against e. coli septicaemia in poultry
IPC: A61P31/04
Filed: 1988-10-14
Abstract: The present invention is concerned with vaccines effective in protecting poultry against E.coli septicaemia, which contain or can cause the production of fimbriae of the F11 type or an immunogenic section thereof, or antibodies against these.
[EP0314224A1]
Patent IE-883261-L (IE)
Title: Disulfur analogs of ll-e33288 antitumor agents
IPC: C07H15/20
Filed: 1988-10-28
Abstract: This disclosure describes disulfide analogs of the family of antibacterial and antitumor agents known collectively as the LL-E33288 Complex.
[EP0313874A2]
Patent IE-883674-L (IE)
Title: Apparatus and method for making a post-foaming gel
IPC: B01F5/10
Filed: 1988-12-09
Abstract: An apparatus for making a post-foaming gel comprising, a device for pumping a gel base, a device (34) for measuring the flow rate of the pumped gel base, a device (51) responsive to the measuring device (34) for pumping a foaming agent at a flow rate in a predetermined ratio to the flow rate of the gel base, a device (38) for introducing the foaming agent to the gel base, and a device (84) for forming the gel or emulsion from the introducing device (38).